Journal of Substance Abuse Treatment
Volume 39, Issue 2 , Pages 114-123 , September 2010

Comparison of opiate-primary treatment seekers with and without alcohol use disorder

  • Bryan Hartzler, Ph.D.

      Affiliations

    • Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105-4631, USA
    • Corresponding Author InformationCorresponding author. Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA 98105-4631, USA. Tel.: +1 206 543 8369 (vm); fax: +1 206 543 5473.
    • ,
  • Dennis M. Donovan, Ph.D.

      Affiliations

    • Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105-4631, USA
    • Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98105, USA
    • ,
  • Zhen Huang, M.S.

      Affiliations

    • Duke Clinical Research Institute, Duke University, Durham, NC 27708, USA

Received 27 January 2010 ,Revised 19 April 2010 ,Accepted 5 May 2010.

References 

  1. Aharonovich E, Nguyen HT, Nunes EV. Anger and depressive states among treatment-seeking drug abusers: Testing the psychopharmacological specificity hypothesis. The American Journal on Addictions. 2001;10:327–334
  2. Babor TF. The trouble with alcohol abuse: What are we trying to measure, diagnose, count and prevent?. Addiction. 2008;103:1057–1059
  3. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. West Sussex, UK: John Wiley & Sons, Ltd; 2009;
  4. Brooks, A., Meade, C. S., Sharpe-Potter, J., Lokhnygina, Y., Calsyn, D. A., & Greenfield, S. F. (in press). Gender differences in the rates and correlates of hiv risk behaviors among drug abusers. Substance Use and Misuse.
  5. Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multi-site effectiveness trial. Drug and Alcohol Dependence. 2006;28:301–312
  6. Chatham LR, Rowan-Szal GA, Joe GW, Brown BS, Simpson DD. Heavy drinking in a population of methadone maintained clients. Journal of Studies on Alcohol. 1995;56:417–422
  7. Chatham LR, Rowan-Szal GA, Joe GW, Simpson DD. Heavy drinking, alcohol-dependent vs. nondependent methadone maintenance clients: A follow-up study. Addictive Behaviors. 1997;22:69–80
  8. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine, and alcohol combinations in accidental drug overdose deaths in New York City, 1990–1998. Addiction. 2003;98:739–747
  9. Degenhardt L, Hall T. Patterns of co-morbidity between alcohol use and other substance use in the Australian population. Drug and Alcohol Review. 2003;22:7–13
  10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7:177–188
  11. Dobler-Mikola A, Hittenschwiler J, Meili D, Beck T, Boni E, Modestin J. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. Journal of Substance Abuse Treatment. 2005;29:259–265
  12. Ducharme LJ, Roman PM. Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphen adoption. Journal of Substance Abuse Treatment. 2009;37:90–94
  13. Forman RF, Svikis DS, Montoya ID, Blaine J. Selection of a substance use disorder diagnostic instrument by the national drug abuse treatment Clinical Trials Network. Journal of Substance Abuse Treatment. 2004;27:1–8
  14. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. New York, NY: Springer; 1998;
  15. Hanson GR, Leshner AI, Tai B. Putting drug abuse research to use in real-life settings. Journal of Substance Abuse Treatment. 2002;23:69–70
  16. Hedges L, Olkin I. Statistical methods for meta-analysis. Orlando, FL: Academic Press; 1985;
  17. Hillebrand J, Marsden J, Finch E, Strang J. Excessive alcohol consumption and drinking expectations among clients in methadone maintenance. Journal of Substance Abuse Treatment. 2001;21:155–160
  18. Hudziak JJ, Helzer JE, Wetzel MW, Kessel KB, McGee B, Janca A, et al. The use of the DSM-III-R checklist for initial diagnostic assessments. Comparative Psychiatry. 1993;34:375–383
  19. Joseph H, Appel P. Alcoholism and methadone treatment: Consequences for the patient and program. American Journal of Drug and Alcohol Abuse. 1985;11:37–53
  20. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8–19
  21. Knudsen HK, Ducharme LJ, Roman P m. Research network involvement and addiction treatment center staff: Counselor attitudes toward buprenorphen. The American Journal on Addictions. 2007;16:365–371
  22. Kreek MJ. Using methadone effectively: Achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs. Rockville, MD: National Institute on Drug Abuse; 1991;
  23. Lloyd JJ, Ricketts EP, Havens JR, Cornelius LJ, Bishai D, Huettner S, et al. The relationship between lifetime abuse and suicidal ideation in a sample of injection drug users. Journal of Psychoactive Drugs. 2007;39:159–166
  24. Maddux JF, Elliot B. Problem drinkers among patients on methadone. American Journal of Alcohol Abuse. 1975;2:245–254
  25. Marsch LA, Bickel WK. Heroin and other opioids. In:  Cohen LM,  Collins FL,  Young AM,  McChargue DE,  Leffingwell TR,  Cook KL editor. Pharmacology and treatment of substance abuse: Evidence- and outcome-based perspectives. New York, NY: Taylor & Francis Group; 2009;p. 359–374
  26. McLellan AT, Cacciola J, Alterman AI, Rikoon SH, Carise D. The Addiction Severity Index at 25: Origins, contributions, and transitions. American Journal of Addiction. 2006;15:113–124
  27. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
  28. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the Addiction Severity Index: Reliability and validity from three centers. Journal of Nervous and Mental Disease. 1985;173:412–423
  29. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. Journal of Nervous and Mental Disease. 1980;168:26–33
  30. Miele GM, Carpenter KM, Smith-Cockerham M, Dietz-Trautman K, Blaine J, Hasin DS. Concurrent and predictive validity of the Substance Dependence Severity Scale. Drug and Alcohol Dependence. 2000;59:77–88
  31. Ottomanelli G. Methadone patients and alcohol abuse. Journal of Substance Abuse Treatment. 1999;16:113–121
  32. Oyefeso A, Brown S, Chiang Y, Clancy C. Self-injurious behaviour, traumatic life events and alexithymia among treatment-seeking opiate addicts: Prevalence, pattern and correlates. Drug and Alcohol Dependence. 2008;98:227–234
  33. Rittmannsberger H, Silberbauer C, Lehner R, Ruschak M. Alcohol consumption during methadone maintenance treatment. European Addiction Research. 2000;6:2–7
  34. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology. 2000;32:582–587
  35. Rounsaville BJ, Weissman MM, Kleber HD. The significance of alcoholism in treated opiate addicts. Journal of Nervous and Mental Disease. 1982;170:479–488
  36. Rowan-Szal GA, Chatham LR, Simpson DD. Importance of identifying cocaine and alcohol dependent methadone clients. American Journal on Addictions. 2000;9:38–50
  37. Sebanjo R, Wolff K, Marshall J. Excessive alcohol consumption is associated with reduced quality of life among methadone patients. Addiction. 2006;102:257–263
  38. Selzner ML. The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. American Journal of Psychiatry. 1971;127:1653–1658
  39. Sendi P, Hoffman M, Bucher HC, Erb P, Haller P, Gyr N, et al. Intravenous opiate maintenance in a cohort of injecting drug addicts. Drug and Alcohol Dependence. 2003;69:183–188
  40. Stapleton RD, Comiskey CM. Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland. Drug and Alcohol Dependence. 2010;107:56–61
  41. Stastney D, Potter M. Alcohol abuse by patient undergoing methadone treatment programmes. British Journal of Addiction. 1991;86:307–310
  42. Stimmel B. Methadone maintenance and alcohol use. Rockville, MD: National Institute on Drug Abuse; 1981;
  43. Tai B, Straus MM, Liu D, Jackson R, McCarty DJ. The first decade of the national institute on drug abuse Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment. 2010;38(Suppl. 1):S4–S13
  44. Teplin D, Raz B, Daiter J, Varenbut M, Plater-Zyberk C. Screening for alcohol use patterns among methadone maintenance patients. The American Journal of Drug and Alcohol Abuse. 2007;33:179–183
  45. Westreich LM. Alcohol and mental illness: Clinical focus. Primary Psychiatry. 2005;12:41–46
  46. Wurst FM, Dursteler-MacFarland KM, Auwaerter V, Ergovic S, Thon N, Yegles M, et al. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports. Alcoholism: Clinical and Experimental Research. 2008;32:1–6
  47. Zador S, Sunjic D. Deaths in methadone maintenance treatment in New South Wales, Australia 1990–1995. Addiction. 2000;95:77–84

PII: S0740-5472(10)00102-9

doi: 10.1016/j.jsat.2010.05.008

Journal of Substance Abuse Treatment
Volume 39, Issue 2 , Pages 114-123 , September 2010

Article Tools